Thursday, November 21, 2024 11/21/2024

Coordinating Research on Emerging Arboviral Threats Encoing the Neotropics (CREATE-NEO)

Award Number: U01AI151807
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Abstract

Project Summary In recent decades, Central and South America have experienced spillover of endemic arthropod-borne viruses (arboviruses) from wildlife reservoirs into humans, exchange and recombination of emerging arboviruses within the region, resurgence of arboviruses previously controlled by vaccination or vector control, introduction and spread of novel arboviruses, and exportation of viruses to other regions. Furthermore, there is great concern that newly-introduced Zika virus may spill back into an enzootic transmission cycle in the Americas. Central and South America encompass enormous vertebrate and invertebrate biodiversity, and these species harbor a broad range of arboviruses whose risk of spillover and spread in humans is presently unknown. Increases in the rates of global travel, invasion of novel vector species, urban expansion, deforestation, and global climate change all elevate the risk of further arbovirus emergence, as does the breakdown of public health structures in Venezuela. The Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics (CREATE- NEO) project will provide a network of surveillance sites in the neotropics coupled to cutting-edge modeling approaches in order to anticipate and counter emerging arboviruses. Aim 1 will identify novel and known arboviruses as well as the host-vector networks that sustain transmission of these viruses within the neotropics, map the spatial distribution of these transmission networks, and characterize virus transmission dynamics within these networks. To do so, we will collect mosquitoes and other vectors as well as non-human primates and other vertebrate hosts at multiple sites in areas of high and varied biodiversity in Panama and Brazil and screen these samples for known and novel arboviruses. These data will then be analyzed using niche modeling, machine learning to predict undiscovered hosts and vectors, and dynamical transmission models. Aim 2 will focus on prospective and retrospective analysis of human infection and disease. To do so, we will leverage ongoing human clinical cohorts at multiple sites in Brazil and Panama. We will extend and expand these cohorts, with a particular focus on the immune-mediated interactions among multiple arboviruses at sites of hyperendemicity. We will also develop novel diagnostics to capture known and novel arboviruses and model the impact of human and non-human primate movement on spillover and spillback of target arboviruses. Data and models generated via these two aims will forewarn local, regional and global public health agencies of arboviruses within Central and South America that pose particularly high risk of spillover, emergence into transmission among humans, and/or international spread. Moreover CREATE-NEO will build local capacity to predict, detect and respond to emerging arboviruses at their point of origin, thereby maximizing the potential to avert full-blown emergence.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2024	UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON	301 UNIVERSITY BLVD	GALVESTON	TX	77555	GALVESTON	USA	Allergy and Infectious Diseases Research	000	5	11/1/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $1,548,235 )
2024	2024	UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON	301 UNIVERSITY BLVD	GALVESTON	TX	77555	GALVESTON	USA	Allergy and Infectious Diseases Research	002	5	6/11/2024	NON-COMPETING CONTINUATION	$1,548,235
2024	2023	UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON	301 UNIVERSITY BLVD	GALVESTON	TX	77555	GALVESTON	USA	Allergy and Infectious Diseases Research	001	4	3/14/2024	NON-COMPETING CONTINUATION	$0
2024	2023	UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON	301 UNIVERSITY BLVD	GALVESTON	TX	77555	GALVESTON	USA	Allergy and Infectious Diseases Research	000	4	11/1/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $1,548,235

Issue Date FY: 2023 ( Subtotal = $1,497,884 )
2023	2023	UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON	301 UNIVERSITY BLVD	GALVESTON	TX	77555	GALVESTON	USA	Allergy and Infectious Diseases Research	004	4	5/25/2023	NON-COMPETING CONTINUATION	$1,544,479
2023	2022	UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON	301 UNIVERSITY BLVD	GALVESTON	TX	77555	GALVESTON	USA	Allergy and Infectious Diseases Research	001	3	2/24/2023	NON-COMPETING CONTINUATION	$0
2023	2022	UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON	301 UNIVERSITY BLVD	GALVESTON	TX	77555	GALVESTON	USA	Allergy and Infectious Diseases Research	003	3	3/7/2023	NON-COMPETING CONTINUATION	$0
2023	2021	UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON	301 UNIVERSITY BLVD	GALVESTON	TX	77555	GALVESTON	USA	Allergy and Infectious Diseases Research	005	2	9/20/2023	SUPPLEMENT FOR EXPANSION	-$46,595
2023	2021	UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON	301 UNIVERSITY BLVD	GALVESTON	TX	77555	GALVESTON	USA	Allergy and Infectious Diseases Research	000	2	2/24/2023	NON-COMPETING CONTINUATION	$0
2023	2020	UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON	301 UNIVERSITY BLVD	GALVESTON	TX	77555	GALVESTON	USA	Allergy and Infectious Diseases Research	002	1	2/27/2023	NEW	$0
														Subtotal = $1,497,884

Issue Date FY: 2022 ( Subtotal = $1,536,375 )
2022	2022	UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON	301 UNIVERSITY BLVD	GALVESTON	TX	77555	GALVESTON	USA	Allergy and Infectious Diseases Research	000	3	5/5/2022	NON-COMPETING CONTINUATION	$1,536,375
														Subtotal = $1,536,375

Issue Date FY: 2021 ( Subtotal = $1,843,157 )
2021	2021	UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON	301 UNIVERSITY BLVD	GALVESTON	TX	77555	GALVESTON	USA	Allergy and Infectious Diseases Research	002	2	9/7/2021	SUPPLEMENT FOR EXPANSION	$0
2021	2021	UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON	301 UNIVERSITY BLVD	GALVESTON	TX	77555	GALVESTON	USA	Allergy and Infectious Diseases Research	000	2	5/26/2021	NON-COMPETING CONTINUATION	$1,519,214
2021	2021	UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON	301 UNIVERSITY BLVD	GALVESTON	TX	77555	GALVESTON	USA	Allergy and Infectious Diseases Research	001	2	8/31/2021	SUPPLEMENT FOR EXPANSION	$323,943
														Subtotal = $1,843,157

Issue Date FY: 2020 ( Subtotal = $1,615,615 )
2020	2020	UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON	301 UNIVERSITY BLVD	GALVESTON	TX	77555	GALVESTON	USA	Allergy and Infectious Diseases Research	000	1	5/22/2020	NEW	$1,615,615
														Subtotal = $1,615,615

Grand Total All Awards = $8,041,266

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Coordinating Research on Emerging Arboviral Threats Encoing the Neotropics (CREATE-NEO)

Award Number: U01AI151807

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer